Roche granted FDA Breakthrough Device Designation

Roche announces that the Tina-quant lipoprotein Lp(a) RxDx assay receives Breakthrough Device Designation from the FDA

Related Keywords

Beijing ,China ,Canada ,Canadian ,Matt Sause ,European Atherosclerosis Society ,Canadian Cardiovascular Society ,Amgen ,Heart Society ,European Society Of Cardiology ,National Lipid Association ,Drug Administration ,Product News ,Breakthrough Device Designation ,European Society ,Beijing Heart Society ,